MRI Delta Radiomics to Track Early Changes in Tumor Following Radiation: Application in Glioblastoma Mouse Model
<b>Background/Objectives</b>: Glioblastoma (GBM) is an aggressive and lethal primary brain tumor with a poor prognosis, with a 5-year survival rate of approximately 5%. Despite advances in oncologic treatments, including surgery, radiotherapy, and chemotherapy, survival outcomes have rem...
Saved in:
| Main Authors: | Mohammed S. Alshuhri, Haitham F. Al-Mubarak, Abdulrahman Qaisi, Ahmad A. Alhulail, Abdullah G. M. AlMansour, Yahia Madkhali, Sahal Alotaibi, Manal Aljuhani, Othman I. Alomair, A. Almudayni, F. Alablani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/4/815 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal Cancer
by: Nicolò Gennaro, et al.
Published: (2025-02-01) -
Delta-radiomics analysis based on magnetic resonance imaging to identify radiation proctitis in patients with cervical cancer after radiotherapy
by: Jing Xue, et al.
Published: (2025-01-01) -
A study on the prediction of targeted therapy efficacy in advanced lung adenocarcinoma patients with EGFR mutations using CT-based delta-radiomics model
by: Zekai Wu, et al.
Published: (2025-05-01) -
CT delta-radiomics predicts the risks of blood transfusion and massive bleeding during spinal tumor surgery
by: Suwei Liu, et al.
Published: (2025-06-01) -
Delta-radiomics Entropy Based on Tumor Heterogeneity Concept – Response Predictor to Irradiation for Unresectable/recurrent Glioblastoma
by: Camil Ciprian MIRESTEAN, et al.
Published: (2022-12-01)